2-(4-Bromophenoxy)tetrahydro-2H-pyran, 95.0%, 500g

N,N-Dimethylhexadecanamide, 95%, 1g

(2S,3R)-3-Fluoro-2-methylazetidine hydrochloride, 97%, 100mg

Methyl 6-bromo-nicotinate, 97.0%, 10g

1-(2-Hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1H-benzo[d]imidazol-2(3H)-one, 98.0%, 1g

Ammonium nitrate matrix modifier solution, 50 g/L NH4NO3 (99.999%) in H2O, 50 mL

2-Bromo-4,6-difluorobenzoic acid, 97%, 10g

n',n'-Diphenyl-1h-pyrrole-2-carbohydrazide, 98%, 250mg

(1E,4E)-1,5-Bis[3,5-bis(methoxymethoxy)phenyl]-1,4-pentadiene-3-one>97.0%(HPLC)20mg

4-Methylisoindoline hydrochloride, 95.0%, 100mg

(S)-2-(4-Hydroxy-2-oxopyrrolidin-1-yl)acetamide, 97.0%, 250mg

1-(2-Chlorothiazol-5-yl)ethan-1-amine hydrochloride, 98%, 250mg

5-Chloromethyl-2-(4-(trifluoromethyl)phenyl)-1H-imidazole, 95.0%, 1g